Production (Stage)
Clene Inc.
CLNN
$2.37
-$0.08-3.27%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.96% | -46.47% | -19.44% | -66.17% | -31.78% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.96% | -46.47% | -19.44% | -66.17% | -31.78% |
| Cost of Revenue | 25.00% | -52.63% | 50.00% | -72.73% | 220.00% |
| Gross Profit | 7.02% | -44.70% | -28.13% | -64.04% | -44.12% |
| SG&A Expenses | -22.34% | -6.76% | -6.90% | -15.55% | -0.55% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -55.33% | -13.41% | -18.11% | -29.45% | -14.15% |
| Operating Income | 55.85% | 12.84% | 18.10% | 28.49% | 13.98% |
| Income Before Tax | 93.22% | -33.19% | -230.27% | 73.01% | 5.86% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 93.22% | -33.19% | -230.27% | 73.01% | 5.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 93.22% | -33.19% | -230.27% | 73.01% | 5.86% |
| EBIT | 55.85% | 12.84% | 18.10% | 28.49% | 13.98% |
| EBITDA | 58.33% | 13.23% | 18.61% | 29.48% | 14.70% |
| EPS Basic | 95.07% | -1.85% | -223.37% | 81.92% | 44.25% |
| Normalized Basic EPS | 95.09% | 0.58% | -120.16% | 82.76% | 43.66% |
| EPS Diluted | 95.07% | -1.85% | -223.37% | 81.92% | 44.25% |
| Normalized Diluted EPS | 95.09% | 0.58% | -120.16% | 82.76% | 43.66% |
| Average Basic Shares Outstanding | 37.43% | 30.77% | 2.14% | 49.29% | 68.87% |
| Average Diluted Shares Outstanding | 37.43% | 30.77% | 2.14% | 49.29% | 68.87% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |